Skip to main content
TipRanks
Go Ultimate75% OFF

Ibi Inv House (IBI) AI Stock Analysis

1 Followers
IL:IBI

Ibi Inv House

(TASE:IBI)

Select Model
Rating:79Outperform
Price Target:ILA 47,289.00â–²(15.59% Upside)
Action:reiterated
Date:09/06/26

The score is driven primarily by strong financial performance—especially excellent cash generation and improved profitability—supported by a clear bullish price trend (price above key moving averages with positive MACD). Offsetting factors are the rise in leverage versus prior years and a relatively elevated P/E multiple, even with a supportive dividend yield.

Positive Factors
Revenue and Profit GrowthAccelerating revenue alongside higher net margins indicates that growth is translating into stronger earnings, not merely expanding activity. If this operating pattern persists, the company should have greater capacity to reinvest, absorb costs, and build earnings power over the next several quarters.
Negative Factors
Rising LeverageThe sharp increase in debt relative to equity reduces financial flexibility compared with 2024 and makes results more sensitive to weaker market conditions. Higher leverage can also constrain future capital allocation, particularly if earnings or asset values become less supportive.

Ibi Inv House (IBI) vs. iShares MSCI Israel ETF (EIS)

-25%0%25%50%75%100%125%IL:IBI+61.89%EIS+10.58%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
ILS 5.80B
Dividend Yield
3.57%
Average Volume (3M)
13.74K
Price to Earnings (P/E)
21.7
Beta (1Y)
1.54
Revenue Growth
44.48%
EPS Growth
91.88%
Country
Israel
Employees
1,078
Sector
General
Sector Strength
55
Industry
Investment - Banking & Investment Services

Ibi Inv House Business Overview & Revenue Model

Company Description

I.B.I. Investment House Ltd provides various financial products and services in Israel and internationally. The company offers equity plan services, financial trusts, mergers and acquisitions, SmartForm, S CUBE valuations, IBI TRUST IL, IBI internati...

Ibi Inv House Financial Statement Overview

Summary

Strong TTM performance with meaningfully higher revenue and improving profitability (net margin ~15% vs ~12% in 2025) alongside robust operating leverage (EBIT ~34%, EBITDA ~38%). Cash generation is a standout (operating cash flow ~2.0x net income; FCF ~0.96x net income), supporting earnings quality. Main risk is balance-sheet leverage rising versus 2024 (debt-to-equity ~0.52 vs ~0.27), which increases sensitivity in weaker market conditions.

Income Statement

86Very Positive

Balance Sheet

74Positive

Cash Flow

88Very Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.77B1.47B1.04B791.55M660.61M548.65M
Gross Profit1.64B1.40B696.21M511.24M417.09M357.00M
EBITDA675.92M494.39M368.28M293.07M212.29M227.69M
Net Income266.16M174.59M178.14M156.46M90.76M139.58M
Balance Sheet
Total Assets2.30B2.17B1.85B1.27B1.08B1.13B
Cash, Cash Equivalents and Short-Term Investments750.73M604.92M519.23M453.00M246.53M547.09M
Total Debt378.21M429.92M243.90M201.26M154.42M334.90M
Total Liabilities1.10B1.03B750.27M539.07M399.48M521.39M
Stockholders Equity955.54M918.42M899.76M686.62M640.44M575.47M
Cash Flow
Free Cash Flow541.38M290.24M218.35M207.56M45.23M190.60M
Operating Cash Flow563.29M307.53M249.28M269.65M61.11M197.55M
Investing Cash Flow-95.41M-100.26M-97.88M-269.38M-44.08M36.90M
Financing Cash Flow-349.09M-178.80M-141.00K-37.48M-80.76M-196.36M

Ibi Inv House Technical Analysis

Technical Analysis SentimentPositive
Last Price40910.00

Price Trends

50DMA42114.40Negative
100DMA43951.49Negative
200DMA41545.17Negative

Market Momentum

MACD-646.67Negative
RSI51.90Neutral
STOCH78.59Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:IBI, the sentiment is Positive. The current price of 40910.00 is above the 20-day moving average (MA) of 40077.50, below the 50-day MA of 42114.40, and below the 200-day MA of 41545.17, indicating a neutral trend. The MACD of -646.67 indicates Negative momentum. The RSI at 51.90 is Neutral, neither overbought nor oversold. The STOCH value of 78.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:IBI.

Ibi Inv House Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IL:IBI against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IL:IBIIL:IBI79OutperformILS 5.85B21.71―3.57%44.48%91.88%
IL:MRINIL:MRIN74OutperformILS 2.96B20.67―5.13%27.33%20.29%
IL:GNRSIL:GNRS73OutperformILS 5.03B2.79―2.32%73.89%616.40%
IL:MTAVIL:MTAV65NeutralILS 9.76B9.87―2.97%28.78%172.56%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%

* General Sector Average

Performance Comparison

0%50%100%150%IL:IBIIL:LAPDIL:MTAVIL:MRINIL:GNRSIL:MTRDDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IL:IBI and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IL:IBIIBI Investment House Ltd.40910.0015640.1361.89%
IL:LAPDLapidoth Capital Ltd.7428.00-733.40-8.99%
IL:MTAVMeitav Dash Investments Ltd.11100.00-191.73-1.70%
IL:MRINY.D. More Investments Ltd.4008.00-702.17-14.91%
IL:GNRSGeneration Capital Ltd.233.70113.7594.83%
IL:MTRDMeitav Trade Investments Ltd.1796.00-176.19-8.93%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 06, 2026